SSPL Securities Private Limited

Monday 19 May, 2025 12:13 PM

Heritage Foods slumps as Q4 PAT tanks 6% YoY to Rs 38 crore Graphite India Ltd leads gainers in 'A' group NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times Bharat Bijlee Q4 PAT jumps 4% YoY to Rs 49 crore; declares dividend of Rs 35/sh Data Patterns (India) gains after Q4 PAT climbs 60% YoY; recommends final dividend of Rs 7.90/ share Volumes jump at Delhivery Ltd counter NSE SME Virtual Galaxy soar into orbit on market debut Protean eGov Tech tanks after exclusion from PAN 2.0 project bidding process Sun Pharma rises after USFDA approves next-gen Blue Light PDT device for actinic keratosis Nesco slides after Q4 PAT decline 16% YoY to Rs 89 cr; recommends final dividend of Rs 6.5/ share GPT Infra rises after Q4 PAT climbs 50% YoY to Rs 24 cr Divis Lab gains after Q4 PAT climbs 23% YoY; recommends final dividend of Rs 30/ share Real Estate shares gain Delhivery sizzles after reporting turnaround Q4 numbers Bharat Electronics gains on bagging Rs 572 cr defence orders

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

DRL's USA facility gets 2 observations from USFDA

19-May-25 08:32 Hrs IST

The USFDA completed aforementioned inspection and issued form-483 with two observations.

Hyderabad-based Dr. Reddy's Laboratories is a global pharmaceutical company. It offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.

The company reported a consolidated net profit of Rs 1,594 crore for the quarter ended March 2025 (Q4FY25), marking a 22% year-on-year increase from Rs 1,307 crore in the same period last year. Revenue from operations rose 20% year-on-year to Rs 8,506 crore, compared to Rs 7,083 crore in Q4FY24.

The counter shed 0.35% to end at Rs 1,230.50 on Friday, 16 May 2025.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 40947467

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)